Consensus statement recommends routine non-fasting lipid profile testing in clinical populations, indicating that non-fasting measurements simplify cardiovascular risk assessment.
We recommend that non-fasting blood samples be routinely used for the assessment of plasma lipid profiles. Laboratory reports should flag abnormal values on the basis of desirable concentration cut-points. Non-fasting and fasting measurements should be complementary but not mutually exclusive.
No takes yet. Share an insight, caveat, or question.
Nordestgaard et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: